Fatty Acid Desaturase 1 (human recombinant)
|
|
- $528
- Product name: Fatty Acid Desaturase 1 (human recombinant)
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:Fatty Acid Desaturase 1 (human recombinant)
1 prices
Selected condition：
Brand
- Cayman Chemical
Package
- 100μg
- ManufacturerCayman Chemical
- Product number25827
- Product descriptionFatty Acid Desaturase 1 (human recombinant) ≥80%estimatedbySDS-PAGE
- Packaging100μg
- Price$528
- Updated2026-04-30
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Cayman Chemical | 25827 | Fatty Acid Desaturase 1 (human recombinant) ≥80%estimatedbySDS-PAGE | 100μg | $528 | 2026-04-30 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|
Description
Fatty acid desaturase 1 (FADS1), also known as Δ5 desaturase, is a 444-amino acid transmembrane protein encoded by FADS1. This product is the N-terminal cytoplasmic domain of FADS1, corresponding to residues 2-121 of the full-length sequence. It catalyzes conversion of dihomo-γ-linolenic acid to arachidonic acid and ω-3 arachidonic acid to eicosapentaenoic acid (Item Nos. 90110 | 90110.1 | 21908) during the production of ω-6 and ω-3 long-chain polyunsaturated fatty acids (LC-PUFAs), respectively. Hepatic FADS1 protein levels and mRNA expression are increased in mice with high-fat diet-induced obesity and non-alcoholic steatohepatitis (NASH). Tissue-selective knockdown of fads1 in the liver, adipose tissue, and reticuloendothelial system of adult hyperlipidemic LDL receptor-null mice promotes hepatic inflammation and formation of atherosclerotic plaques and suppresses hepatic lipogenesis. Increased expression of FADS1 positively correlates with disease-free survival and overall survival times in patients with esophageal squamous cell carcinoma (ESCC).More related product prices